Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTO '336 - app.#90/009,457 ..now looking at older documents as well.

Might as well throw in the 749 as well.

There the examiner considered the 7/17/09 IDS of 54 pages submitted by the patent holder. Also went way back to the 3/31/08 IDS of 1 page submitted by the reexam requestor. I'm sure that we responded to the old request for reexam sufficiently and there would be no need to consider it again unless it was to defeat similar prior art in pending requests for reexam.

So here it looks to me like gearing up for a recert. Again, my theory my have holes, so don't do anything based soley on an untested theory.

GLTA, Opty

Share
New Message
Please login to post a reply